| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/30/2000 | CA1341011C Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives |
| 05/25/2000 | WO2000028988A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | CA2349575A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| 05/24/2000 | EP1001777A1 Fibrinogen receptor antagonists |
| 05/24/2000 | EP1001776A1 Aroylpiperazines for modulating sexual activity |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/23/2000 | US6066735 Treatment of erectile dysfunction |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 05/23/2000 | CA2290249A1 Polysulfide solutions and hydroxyalkyl aminium ions for stabilizing elemental sulfur |
| 05/18/2000 | WO2000027855A1 Chiral ligands for asymmetric catalysis |
| 05/18/2000 | WO2000027843A1 Ccr-3 receptor antagonists |
| 05/18/2000 | WO2000027833A1 Drug dependence remedies |
| 05/18/2000 | WO2000027826A1 Novel pyrimidines, the production thereof and their use |
| 05/18/2000 | WO2000027808A1 N-arylsulfonyl amino acid omega amides |
| 05/18/2000 | WO2000027800A1 Ccr-3 receptor antagonists |
| 05/18/2000 | WO2000027790A1 Mutilin compounds |
| 05/18/2000 | WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | WO2000010544A3 A method for preventing the onset of asthma |
| 05/18/2000 | WO2000006140A3 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 05/18/2000 | CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | CA2347146A1 Chiral ligands for asymmetric catalysis |
| 05/17/2000 | EP1000934A2 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane compounds |
| 05/17/2000 | EP1000090A1 Novel photoinitiators and applications therefor |
| 05/17/2000 | EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 05/17/2000 | EP1000047A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 05/17/2000 | EP1000046A1 Piperazine derivatives active on the lower urinary tract |
| 05/17/2000 | EP1000043A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 05/17/2000 | EP1000023A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | EP1000016A1 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives. |
| 05/17/2000 | EP1000012A1 Process for converting propargylic amine-n-oxides to enaminones |
| 05/17/2000 | EP0999840A1 Use of draflazine-analogues for treating pain |
| 05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
| 05/17/2000 | CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253547A 1,4-substituted cyclic amine derivatives |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/16/2000 | US6063792 Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-trihexyphenidyl |
| 05/16/2000 | CA2289827A1 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane |
| 05/11/2000 | WO2000026189A1 Method for producing nitroxyl compounds of secondary amines |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | DE19851421A1 Neue Pyrimidine, deren Herstellung und Verwendung New pyrimidines, their preparation and use |
| 05/11/2000 | DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides |
| 05/10/2000 | EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/10/2000 | EP0999205A1 Aminocycloalkane compounds |
| 05/10/2000 | EP0999204A1 Novel compound having effect of promoting neuron differentiation |
| 05/10/2000 | EP0998469A1 Benzamide cycloalkyl stimulating high and low gastrointestinal motricity |
| 05/10/2000 | EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 05/10/2000 | EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 05/10/2000 | EP0685234B1 Drug composition containing nucleic acid copolymer |
| 05/10/2000 | CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them |
| 05/10/2000 | CN1052228C Preparing method for n-formyl piperidine and homologs thereof |
| 05/09/2000 | US6060513 Compounds and compositions for delivering active agents |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/09/2000 | US6060492 Side effect reduction |
| 05/09/2000 | US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/04/2000 | WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/04/2000 | WO2000024394A1 Antitumor chrysene derivatives |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO2000006139A3 Use of moclobemide and metabolites for treating and preventing substance abuse |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | DE19850625A1 Verfahren zur Herstellung von Nitroxylverbindugen sekundärer Amine A process for preparing secondary amines Nitroxylverbindugen |
| 05/04/2000 | CA2346873A1 Antitumor chrysene derivatives |
| 05/03/2000 | EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds |
| 05/03/2000 | EP0997147A1 Amino acid derivatives |
| 05/03/2000 | EP0996614A1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 05/03/2000 | EP0996440A1 Method for treatment of glutamate related disorders |
| 05/03/2000 | EP0996434A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 05/03/2000 | EP0996433A1 Methods for treatment of conditions associated with lactosylceramide |
| 05/03/2000 | EP0861233B1 N-protected/n-substituted-beta-amino hydroxy sulfonates |
| 05/03/2000 | CN1252050A Hydrogenation of imine and enamine |
| 05/02/2000 | US6057443 Dimorpholinodiethylether having improved isocyanate stability |
| 05/02/2000 | US6057442 Preparation of amines |
| 05/02/2000 | US6057419 Drugs and images |
| 05/02/2000 | US6057371 Sigma receptor ligands and the use thereof |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057358 Amine derivatives, processes for producing them and a use of them as antiarrhythmic drugs |
| 05/02/2000 | US6057323 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 04/27/2000 | WO2000023420A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 04/27/2000 | WO2000023419A1 Novel prodrugs of non-steroidal anti-inflammatory carboxylic acids, their preparation and use |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | CA2348159A1 Aromatic amine derivatives, their production and use |
| 04/26/2000 | EP0995741A1 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
| 04/26/2000 | EP0994884A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 04/26/2000 | EP0994862A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 04/26/2000 | EP0994848A1 Glucagon antagonists/inverse agonists |
| 04/26/2000 | EP0994712A1 Inhibitors of neutrophil mediated oxidant production |
| 04/26/2000 | EP0994710A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 04/26/2000 | EP0973737A4 Efficient synthesis of a chiral mediator |
| 04/26/2000 | EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |